On the public citation graph
Approval success rates of drug candidates based on target, action, modality, application, and their combinations
0 signed · 140 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/(sici)1098-2795(199812)51:4<477::aid-mrd17>3.0.co;2-wopenalex-snapshot
Essential cell biology
inferredcites →https://doi.org/10.1016/j.drudis.2011.12.020openalex-snapshot
Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
inferredcites →https://doi.org/10.1016/j.jhealeco.2016.01.012openalex-snapshot
Innovation in the pharmaceutical industry: New estimates of R&D costs
inferredcites →https://doi.org/10.1038/clpt.2009.295openalex-snapshot
Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs
inferredcites →https://doi.org/10.1038/clpt.2013.117openalex-snapshot
Clinical Approval Success Rates for Investigational Cancer Drugs
inferredcites →https://doi.org/10.1038/d41573-019-00074-zopenalex-snapshot
Trends in clinical success rates and therapeutic focus
inferredcites →https://doi.org/10.1038/nbt.2786openalex-snapshot
Clinical development success rates for investigational drugs
inferredcites →https://doi.org/10.1038/nbt0905-1073openalex-snapshot
Monoclonal antibody successes in the clinic
inferredcites →https://doi.org/10.1038/ng.3314openalex-snapshot
The support of human genetic evidence for approved drug indications
inferredcites →https://doi.org/10.1038/nrd.2016.230openalex-snapshot
A comprehensive map of molecular drug targets
inferredcites →https://doi.org/10.1038/nrd.2017.178openalex-snapshot
Trends in GPCR drug discovery: new agents, targets and indications
inferredcites →https://doi.org/10.1038/nrd.2017.194openalex-snapshot
Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications
inferredcites →https://doi.org/10.1038/nrd1470openalex-snapshot
Can the pharmaceutical industry reduce attrition rates?
inferredcites →https://doi.org/10.1038/nrd2132openalex-snapshot
Drugs, their targets and the nature and number of drug targets
inferredcites →https://doi.org/10.1038/nrd2758openalex-snapshot
Do molecularly targeted agents in oncology have reduced attrition rates?
inferredcites →https://doi.org/10.1038/nrd2805openalex-snapshot
Averting inflammation by targeting the cytokine environment
inferredcites →https://doi.org/10.1038/nrd3078openalex-snapshot
How to improve R&D productivity: the pharmaceutical industry's grand challenge
inferredcites →https://doi.org/10.1038/nrd3405openalex-snapshot
The productivity crisis in pharmaceutical R&D
inferredcites →https://doi.org/10.1038/nrd3681openalex-snapshot
Diagnosing the decline in pharmaceutical R&D efficiency
inferredcites →https://doi.org/10.1038/nrd4164openalex-snapshot
Does size matter in R&D productivity? If not, what does?
inferredcites →https://doi.org/10.1038/nrd4309openalex-snapshot
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
inferredcites →https://doi.org/10.1038/s41573-019-0049-9openalex-snapshot
Therapies for rare diseases: therapeutic modalities, progress and challenges ahead
inferredcites →https://doi.org/10.1038/s41573-020-0078-4openalex-snapshot
Soluble ligands as drug targets
inferredcites →https://doi.org/10.1067/mcp.2001.115446openalex-snapshot
Risks in new drug development: Approval success rates for investigational drugs
inferredcites →https://doi.org/10.1093/biostatistics/kxx069openalex-snapshot
Estimation of clinical trial success rates and related parameters
inferredcites →https://doi.org/10.1383/anes.5.10.350.52312openalex-snapshot
Receptors, agonists and antagonists
inferredcites →https://doi.org/10.1533/9781908818287.1openalex-snapshot
Membrane transporters and the diseases corresponding to functional defects
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/adsr.202500155openalex-snapshot
Novel Technologies for Exploring the Skin–Brain Axis
inferred← citeshttps://doi.org/10.1002/ddr.70152openalex-snapshot
Exploring the Topoisomerase II Inhibitory Potential of Steroidal Drugs as a Recommended Mechanism of Action for Their Anticancer Activity: In Silico and In Vitro Assessments
inferred← citeshttps://doi.org/10.1002/jcph.2063openalex-snapshot
Combinations of Drug Candidate Properties Affecting Development Success and Discontinuation for 5 Diseases: Lymphoma, Non–Small Cell Lung Cancer, Arthritis, Depression, and Alzheimer Disease
inferred← citeshttps://doi.org/10.1002/jcph.70002openalex-snapshot
Navigating First‐in‐Human and Early‐Phase Patient Studies: Study Designs, Risk Mitigation, and Population Selection Challenges
inferred← citeshttps://doi.org/10.1002/pst.2316openalex-snapshot
Replenishing the pipeline: A quantitative approach to optimising the sourcing of new projects
inferred← citeshttps://doi.org/10.1002/smll.202402431openalex-snapshot
Lubricant‐Coated Organ‐on‐a‐Chip for Enhanced Precision in Preclinical Drug Testing
inferred← citeshttps://doi.org/10.1007/7355_2026_191openalex-snapshot
The Role of Artificial Intelligence for Drug Repurposing in Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-3-031-62007-2_14openalex-snapshot
Biopharmaceutical Informatics: A Strategic Vision for Discovering Developable Biotherapeutic Drug Candidates
inferred← citeshttps://doi.org/10.1007/978-3-031-98022-0_25openalex-snapshot
Leveraging Generative AI in Clinical Studies to Improve Efficiency and Quality of Drug Development
inferred← citeshttps://doi.org/10.1007/978-981-95-8938-8_7openalex-snapshot
Cancer Signaling Pathways and Cancer Biology
inferred← citeshttps://doi.org/10.1007/978-981-97-0221-3_6openalex-snapshot
Advances in Electrospinning Technology for Fast-Dissolving Oral Film Applications
inferred← citeshttps://doi.org/10.1007/s11030-025-11114-9openalex-snapshot
Optimizing kinase and PARP inhibitor combinations through machine learning and in silico approaches for targeted brain cancer therapy
inferred← citeshttps://doi.org/10.1007/s12519-024-00836-9openalex-snapshot
Neonatal encephalopathy due to suspected hypoxic ischemic encephalopathy: pathophysiology, current, and emerging treatments
inferred← citeshttps://doi.org/10.1007/s40290-023-00499-3openalex-snapshot
Drug Repurposing for Spinal Cord Injury: Progress Towards Therapeutic Intervention for Primary Factors and Secondary Complications
inferred← citeshttps://doi.org/10.1007/s40336-022-00530-8openalex-snapshot
“It is folly to measure the true and the false by our own capacity”—M. de Montaigne
inferred← citeshttps://doi.org/10.1016/j.addr.2022.114584openalex-snapshot
Photonic and magnetic materials for on-demand local drug delivery
inferred← citeshttps://doi.org/10.1016/j.addr.2025.115702openalex-snapshot
In vitro models of the interplay between glioblastoma and blood–brain barrier for stratifying drug efficacy
inferred← citeshttps://doi.org/10.1016/j.bbadis.2022.166552openalex-snapshot
Novel epigenetic therapeutic strategies and targets in cancer
inferred← citeshttps://doi.org/10.1016/j.bcp.2024.116255openalex-snapshot
Mechanotransduction and the extracellular matrix: Key drivers of lung pathologies and drug responsiveness
inferred← citeshttps://doi.org/10.1016/j.biotechadv.2021.107883openalex-snapshot
Capturing the third dimension in drug discovery: Spatially-resolved tools for interrogation of complex 3D cell models
inferred← citeshttps://doi.org/10.1016/j.chembiol.2023.06.014openalex-snapshot
Integrating inflammatory biomarker analysis and artificial-intelligence-enabled image-based profiling to identify drug targets for intestinal fibrosis
inferred← citeshttps://doi.org/10.1016/j.compbiolchem.2026.109245openalex-snapshot
Classical substructure search versus LLM-assisted keyword retrieval in SciFinder: A case study on GABAB1 ligand discovery using a phenibut scaffold
inferred← citeshttps://doi.org/10.1016/j.conctc.2025.101590openalex-snapshot
Strategic risk assessment in oncology: Utilizing single-agent activity to boost combination therapy approvals
inferred← citeshttps://doi.org/10.1016/j.csbj.2025.07.040openalex-snapshot
Substituted 1,4-naphthoquinones for potential anticancer therapeutics: In vitro cytotoxic effects and QSAR-guided design of new analogs
inferred← citeshttps://doi.org/10.1016/j.drudis.2024.103919openalex-snapshot
Unveiling the impacts of FDA Breakthrough Therapy Designation: a dual-perspective examination of economic and developmental outcomes for biotechnology companies
inferred← citeshttps://doi.org/10.1016/j.drudis.2025.104453openalex-snapshot
Commercialization of cell and gene therapy in Canada: Current landscape, challenges and opportunities
inferred← citeshttps://doi.org/10.1016/j.drudis.2026.104636openalex-snapshot
Antibody–drug conjugates: from efficacy testing to bioassay evaluation in modern drug development
inferred← citeshttps://doi.org/10.1016/j.ejmcr.2025.100320openalex-snapshot
Exploiting the synergy between computational and experimental biophysics for efficient cancer drug development
inferred← citeshttps://doi.org/10.1016/j.ejphar.2023.175668openalex-snapshot
Perspective insights of small molecules, phytoconstituents and biologics in the management of psoriasis: A focus on targeting major inflammatory cytokine pathways
inferred← citeshttps://doi.org/10.1016/j.gendis.2024.101402openalex-snapshot
Insights into targeting LKB1 in tumorigenesis
inferred← citeshttps://doi.org/10.1016/j.ibmed.2023.100101openalex-snapshot
Machine learning for metabolomics research in drug discovery
inferred← citeshttps://doi.org/10.1016/j.jcf.2023.07.006openalex-snapshot
Traits, trends and hits of orphan drug designations in cystic fibrosis
inferred← citeshttps://doi.org/10.1016/j.jddst.2024.105826openalex-snapshot
Folate titanium (IV)-chitosan nanocomposites as drug delivery system for active-targeted cancer therapy: Design, HSA/GSH binding, mechanistic, and biological investigations
inferred← citeshttps://doi.org/10.1016/j.nanoen.2023.108731openalex-snapshot
Passivation strategies for enhancing device performance of perovskite solar cells
inferred← citeshttps://doi.org/10.1016/j.phrs.2023.106830openalex-snapshot
Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation
inferred← citeshttps://doi.org/10.1016/j.respol.2023.104938openalex-snapshot
The interdependent influence of lobbying and intellectual capital on new drug development
inferred← citeshttps://doi.org/10.1016/j.slast.2026.100434openalex-snapshot
End-to-end automation of organ-on-a-chip culture and drug testing: Enhancing scalability and expandability
inferred← citeshttps://doi.org/10.1016/j.wpi.2025.102381openalex-snapshot
Quantitative insights on artificial intelligence in the pharmaceutical industry: A patent-basis analysis of technological trends and key players
inferred← citeshttps://doi.org/10.1021/acs.cgd.3c01390openalex-snapshot
Pharmaceutical Digital Design: From Chemical Structure through Crystal Polymorph to Conceptual Crystallization Process
inferred← citeshttps://doi.org/10.1021/acs.chemrev.2c00915openalex-snapshot
The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics
inferred← citeshttps://doi.org/10.1021/acs.orglett.5c04049openalex-snapshot
One-Pot Bioisosteric Replacement of Alkyl Carboxylic Acids via Organic Photoredox Catalysis
inferred← citeshttps://doi.org/10.1021/acsanm.2c01118openalex-snapshot
Carbon Nanotubes in Tumor-Targeted Chemotherapeutic Formulations: A Review of Opportunities and Challenges
inferred← citeshttps://doi.org/10.1021/acsbiomaterials.6c00550openalex-snapshot
Face Scrubber-Fabricated Affordable and User-Friendly Microwell Devices for Scalable 3D Cell Culture
inferred← citeshttps://doi.org/10.1038/d41573-024-00002-wopenalex-snapshot
Disproportional inflation of clinical trial costs: why we should care, and what we should do about it
inferred← citeshttps://doi.org/10.1038/s41467-024-48864-3openalex-snapshot
Roadblocks confronting widespread dissemination and deployment of Organs on Chips
inferred← citeshttps://doi.org/10.1038/s41467-025-64552-2openalex-snapshot
Dynamic clinical trial success rates for drugs in the 21st century
inferred← citeshttps://doi.org/10.1038/s41551-025-01491-9openalex-snapshot
An immune-competent lung-on-a-chip for modelling the human severe influenza infection response
inferred← citeshttps://doi.org/10.1038/s41573-023-00704-7openalex-snapshot
Amplifying gene expression with RNA-targeted therapeutics
inferred← citeshttps://doi.org/10.1038/s41598-026-43782-4openalex-snapshot
A dual-branch graph neural network architecture for drug-target binding affinity prediction
inferred← citeshttps://doi.org/10.1038/s41746-025-02143-7openalex-snapshot
Explainable AI-driven precision clinical trial enrichment: demonstration of the NetraAI platform with a phase II depression trial
inferred← citeshttps://doi.org/10.1039/d4lc00990hopenalex-snapshot
Real-time and regional analysis of the efficacy of anticancer drugs in a patient-derived intratumoral heterogeneous tumor microenvironment
inferred← citeshttps://doi.org/10.1073/pnas.2426481122openalex-snapshot
Flycodes enable simultaneous preclinical analysis for dozens of antibodies in single cassette–dosed mice
inferred← citeshttps://doi.org/10.1080/14656566.2025.2536352openalex-snapshot
Profiling opnurasib (JDQ-443) for the treatment of non-small cell lung cancer (NSCLC)
inferred← citeshttps://doi.org/10.1088/1758-5090/ae9807openalex-snapshot
Sequential stenciling to reconstitute 2D microtissues for multicellular and synthetic signaling architectures
inferred← citeshttps://doi.org/10.1093/9780198945239.003.0074openalex-snapshot
The Propaganda Narrative Behind Animal Experimentation
inferred← citeshttps://doi.org/10.1093/bib/bbac326openalex-snapshot
Viral informatics: bioinformatics-based solution for managing viral infections
inferred← citeshttps://doi.org/10.1093/bioadv/vbaf043openalex-snapshot
Drug target assessments: classifying target modulation and associated health effects using multi-level BERT-based classification models
inferred← citeshttps://doi.org/10.1093/eurheartj/ehae519openalex-snapshot
Clinical trials in-a-dish for cardiovascular medicine
inferred← citeshttps://doi.org/10.1093/nargab/lqab113openalex-snapshot
Supervised learning with word embeddings derived from PubMed captures latent knowledge about protein kinases and cancer
inferred← citeshttps://doi.org/10.1101/2022.08.16.504181openalex-snapshot
Antibody optimization enabled by artificial intelligence predictions of binding affinity and naturalness
inferred← citeshttps://doi.org/10.1101/2024.02.26.24303388openalex-snapshot
Dynamic Clinical Success Rates for Drugs in the 21st Century
inferred← citeshttps://doi.org/10.1101/2025.03.16.643501openalex-snapshot
A hybrid machine learning framework leveraging biophysicochemical insights for scalable discovery of protein-ligand interactions
inferred← citeshttps://doi.org/10.1101/2025.05.15.25327693openalex-snapshot
Calendar Period Estimation of Probabilities of Transition in Drug Development
inferred← citeshttps://doi.org/10.1109/access.2025.3552256openalex-snapshot
A Survey of Large Language Model for Drug Research and Development
inferred← citeshttps://doi.org/10.1109/iconstem60960.2024.10568895openalex-snapshot
Machine Learning-Assisted Protein Structure Prediction: An AI Approach for Biochemical Insights
inferred← citeshttps://doi.org/10.1111/cbdd.14092openalex-snapshot
Predicting clinical trial outcomes using drug bioactivities through graph database integration and machine learning
inferred← citeshttps://doi.org/10.1111/cts.70650openalex-snapshot
Benzbromarone as a Novel Candidate for Preventing Alzheimer's Disease: Evidence From Real‐World Data Screening and in Vitro Validation
inferred← citeshttps://doi.org/10.1126/scitranslmed.adg2970openalex-snapshot
Biological therapies need definitive randomized controlled clinical trials
inferred← citeshttps://doi.org/10.1159/000551962openalex-snapshot
Understanding Late-Stage Clinical Trial Failure in Multiple Sclerosis: Insights from ClinicalTrials.gov
inferred← citeshttps://doi.org/10.1177/02698811251360754openalex-snapshot
Appraisal of the validity of preclinical investigations to predict the efficacy of psychedelic drugs as fast-acting antidepressants
inferred← citeshttps://doi.org/10.1177/17407745221147689openalex-snapshot
Now is the time to fix the evidence generation system
inferred← citeshttps://doi.org/10.1177/17588359261446794openalex-snapshot
Driving precision medicine in testicular germ cell tumors: from preclinical models to clinical applications
inferred← citeshttps://doi.org/10.1182/bloodadvances.2023011730openalex-snapshot
Successes and pitfalls in orphan drug development for sickle cell disease
inferred← citeshttps://doi.org/10.1183/16000617.0042-2023openalex-snapshot
Innovative three-dimensional models for understanding mechanisms underlying lung diseases: powerful tools for translational research
inferred← citeshttps://doi.org/10.1186/s12931-023-02446-xopenalex-snapshot
A polo-like kinase inhibitor identified by computational repositioning attenuates pulmonary fibrosis
inferred← citeshttps://doi.org/10.1186/s43556-026-00498-1openalex-snapshot
Artificial intelligence and ultra-high performance computing methods and experiments for drug discovery: virtual screening, deep learning, molecular dynamics simulations, ADMET modelling, and experimental validation
inferred← citeshttps://doi.org/10.1248/yakushi.25-00015openalex-snapshot
Toward Establishing a Japanese Drug Discovery Ecosystem: The Role of Startups and a Model Tailored to Japan
inferred← citeshttps://doi.org/10.20935/acaddrug8407openalex-snapshot
Model-optimized bispecific antibodies improve the selectivity of antibody–drug conjugates for tumors
inferred← citeshttps://doi.org/10.21037/tp-22-687openalex-snapshot
Biological and structural phenotypes associated with neurodevelopmental outcomes in congenital heart disease
inferred← citeshttps://doi.org/10.21203/rs.3.rs-2320212/v1openalex-snapshot
A polo-like kinase inhibitor identified by computational repositioning attenuates pulmonary fibrosis
inferred← citeshttps://doi.org/10.21203/rs.3.rs-4053961/v1openalex-snapshot
Dynamic Clinical Success Rates for Drugs in the 21st Century
inferred← citeshttps://doi.org/10.2174/0115680266264349231016094456openalex-snapshot
Phytochemicals Showing Antiangiogenic Effect in Pre-clinical Models and their Potential as an Alternative to Existing Therapeutics
inferred← citeshttps://doi.org/10.3389/fchem.2026.1886764openalex-snapshot
Flexible molecular chameleons: structural adaptability and therapeutic applications
inferred← citeshttps://doi.org/10.3389/fmed.2026.1837248openalex-snapshot
Regulatory Science: exploring an emerging scientific discipline in health care
inferred← citeshttps://doi.org/10.3389/fmolb.2025.1568437openalex-snapshot
Editorial: Machine learning in computer-aided drug design
inferred← citeshttps://doi.org/10.3389/fphar.2022.923353openalex-snapshot
Structural Modification in Anesthetic Drug Development for Prodrugs and Soft Drugs
inferred← citeshttps://doi.org/10.3389/fphar.2024.1442752openalex-snapshot
Integrating text mining with network models for successful target identification: in vitro validation in MASH-induced liver fibrosis
inferred← citeshttps://doi.org/10.3389/fpubh.2022.1044702openalex-snapshot
Becoming an Agile Change Conductor
inferred← citeshttps://doi.org/10.3389/frhs.2024.1376695openalex-snapshot
Creating demand for unmet needs: Agile Storytelling
inferred← citeshttps://doi.org/10.3390/applbiosci4020023openalex-snapshot
Can Caenorhabditis elegans Serve as a Reliable Model for Drug and Nutraceutical Discovery?
inferred← citeshttps://doi.org/10.3390/biom12111559openalex-snapshot
The Pharmacorank Search Tool for the Retrieval of Prioritized Protein Drug Targets and Drug Repositioning Candidates According to Selected Diseases
inferred← citeshttps://doi.org/10.3390/biom14030339openalex-snapshot
Advances in AI for Protein Structure Prediction: Implications for Cancer Drug Discovery and Development
inferred← citeshttps://doi.org/10.3390/biomedicines13030645openalex-snapshot
Absorption of Toxicants from the Ocular Surface: Potential Applications in Toxicology
inferred← citeshttps://doi.org/10.3390/cancers16233980openalex-snapshot
Discovery, Validation and Mechanistic Study of XPO1 Inhibition in the Treatment of Triple-Negative Breast Cancer
inferred← citeshttps://doi.org/10.3390/curroncol33060339openalex-snapshot
Identifying Factors Associated with the Acquisition of Multiple Indications for Anticancer Drugs
inferred← citeshttps://doi.org/10.3390/ijms23073649openalex-snapshot
Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications
inferred← citeshttps://doi.org/10.3390/nano15171354openalex-snapshot
The Use of Computational Approaches to Design Nanodelivery Systems
inferred← citeshttps://doi.org/10.3390/ph16070937openalex-snapshot
Droplet-Based Microfluidics: Applications in Pharmaceuticals
inferred← citeshttps://doi.org/10.3390/v16101622openalex-snapshot
Susceptibility of HPV-18 Cancer Cells to HIV Protease Inhibitors
inferred← citeshttps://doi.org/10.4103/jrpp.jrpp_50_25openalex-snapshot
Evaluating the Role of Machine Learning and Artificial Intelligence in Oncology Drug Repurposing Efforts
inferred← citeshttps://doi.org/10.52547/vacres.9.1.1openalex-snapshot
Vaccine Innovation for Dengue, Chikungunya, Zika and Yellow Fever: Accelerating Global Development Agenda and Partnerships in Post-COVID Era
inferred← citeshttps://doi.org/10.6084/m9.figshare.23290342openalex-snapshot
Additional file 1 of A polo-like kinase inhibitor identified by computational repositioning attenuates pulmonary fibrosis
inferred← citeshttps://doi.org/10.6084/m9.figshare.23290345openalex-snapshot
Additional file 2 of A polo-like kinase inhibitor identified by computational repositioning attenuates pulmonary fibrosis
inferred← citeshttps://doi.org/10.61186/vacres.9.2.1openalex-snapshot
Vaccine Innovation for Dengue, Chikungunya, Zika and Yellow Fever: Accelerating Global Development Agenda and Partnerships in Post-COVID Era
inferred← citeshttps://doi.org/10.64628/aai.rs79u5sg9openalex-snapshot
90% of drugs fail clinical trials – here’s one way researchers can select better drug candidates
inferred← citeshttps://doi.org/10.64898/2026.01.29.702072openalex-snapshot
TwinCell: Large Causal Cell Model for Reliable and Interpretable Therapeutic Target Prioritisation
inferred← citeshttps://doi.org/10.64898/2026.03.19.26348323openalex-snapshot
Mapping the Clinical Trial Landscape in Anorexia Nervosa: A Registry-Based Analysis of Research Activity and Translational Gaps
inferred← citeshttps://doi.org/10.64898/2026.04.01.715780openalex-snapshot
Reconstituting organotypic 2D microtissue co-cultures via sequential stenciling
inferred← citeshttps://doi.org/10.65391/r1910openalex-snapshot
Red Cars are Killing Left-handed People!
inferred← citeshttps://doi.org/10.70675/5b627e18z2083z415fza14cz173de10466d1openalex-snapshot
Mathematical modelling and learning of biomedical signals for safety pharmacology
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.